KWF: open calls

Funds basic research and credentialing-phase research into the biological or psychosocial mechanisms of cancer onset, growth, spread and impact. Two-stage process via pre-proposal and full proposal submitted through KWF-GMS; registered participating institutes required 6 weeks before closing.

For Dutch academic groups and (spin-off) companies developing novel oncology drug candidates in late-stage preclinical development or approaching first-in-human studies, co-funded with Cancer Research UK's Centre for Drug Development. Applicants must hold or be able to secure IP rights and freedom to operate; non-Dutch initiators and repurposing of registered drugs are out of scope.